Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
---|
10/19/2006 | US20060233704 Prochelator for the preparation of radiometal labeled molecules having improved biological properties |
10/17/2006 | US7122676 Reacting oxalimidic acid dihydrazide with sodium nitrite |
10/17/2006 | CA2318527C Inhibitors of .alpha.4 mediated cell adhesion |
10/11/2006 | EP1709029A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
10/11/2006 | CN1844128A Process for synthesizing tetra-substituted amino macrocyclic metal complex |
10/11/2006 | CN1844110A Method for synthesizing Valsartan with high optical purity |
10/11/2006 | CN1279030C Complex of 3,6-bi(2'-hydroxy-5'-chlorphenyl)-S-tetrazine and transition metal, its preparation and application |
10/10/2006 | US7119097 2-(4,6-dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid; formulations for oral, parenteral, or nasopharyngeal delivery; endothelin receptor antagonist |
10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
10/05/2006 | US20060223872 Insecticidal phthalamide derivatives |
10/05/2006 | CA2600833A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
10/04/2006 | EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds |
10/04/2006 | EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
10/04/2006 | CN1842517A 芴衍生物 Fluorene derivatives |
10/03/2006 | US7115749 For inhibiting hepatitis c virus RNA-dependent polymerase |
10/01/2006 | CA2541379A1 Losartan potassium crystalline form alpha |
09/28/2006 | WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
09/28/2006 | US20060217549 Diamine purification method |
09/28/2006 | US20060217548 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, cyclene and functionalised cyclenes |
09/27/2006 | EP1704150A1 2,3-dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
09/27/2006 | EP1703909A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
09/27/2006 | CN1276922C Metal phthalocyanine derivative, salt and preparing method thereof |
09/26/2006 | CA2243316C Metal complexes that contain perfluoroalkyl, process for their production and their use in nmr diagnosis |
09/21/2006 | WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor |
09/21/2006 | CA2597444A1 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
09/19/2006 | US7109223 neuroprotective effect; potent selective agonists of the EP4 subtype of prostaglandin E2 receptors |
09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
09/19/2006 | US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role |
09/14/2006 | WO2006095771A1 Complex compound and mri probe made of same |
09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
09/13/2006 | EP1699466A2 New compounds useful as metal chelators |
09/13/2006 | CN1832931A A process for the preparation of phenyltetrazole derivatives |
09/13/2006 | CN1832742A Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
09/12/2006 | US7105557 Polymorphs of valsartan |
09/08/2006 | WO2006093864A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use |
09/08/2006 | WO2006023889A3 A method for preparing irbesartan and intermediates thereof |
09/08/2006 | CA2597463A1 Cardiovascular compounds comprising nitric oxide enhancing groups, compositions and methods of use |
09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
09/06/2006 | EP1697292A1 Method for the production of tetrahydrogeranylacetone |
09/06/2006 | CN1273455C Process for preparation of N-1 protected N ring nitrogen -containing cyclic polyamines and products thereof |
09/06/2006 | CN1273448C Method for preparing aryl alkyl hydrogen peroxide |
09/05/2006 | US7102011 Visualizing cellular organelles and cytoskeletons; obtain tissue sample, fix tissue, incubate with crystalizing agents, visualizing cellular organelles, visualize crystals formed in organelles detect numbers and shape of oganelle |
09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
09/05/2006 | US7101895 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
09/05/2006 | US7101449 Method for recovery of nitramines from aluminized energetic materials |
08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
08/30/2006 | EP1695959A1 Compouds and methods for the inhibition of the expression of VCAM-1 |
08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
08/30/2006 | CN1826329A Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same |
08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
08/29/2006 | US7098342 Dehydrohalogenation to form cilexetin trityl candesartan in the presence of phase transfer compounds |
08/29/2006 | US7098212 Piperazine derivatives |
08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
08/24/2006 | WO2006087135A1 Tetrazine derivatives having an antimycotic effect, and use thereof |
08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
08/24/2006 | DE102005007739A1 Tetrazinderivate mit antimykotischer Wirkung und ihre Verwendung Tetrazine derivatives with antifungal activity and their use |
08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
08/23/2006 | CN1823049A Water-soluble tetrazolium compounds |
08/23/2006 | CN1271068C Novel method for preparing olmesartan |
08/22/2006 | US7094807 Viricides; hepatitis virus |
08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
08/17/2006 | WO2006085510A1 Remedy for irritable bowel syndrome |
08/17/2006 | WO2006085111A1 Anthranilic acid derivatives active at the hm74a receptor |
08/17/2006 | WO2006067216A3 Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan |
08/17/2006 | US20060183916 By direct ortho-metallation of (tetrazol-5- gamma l)benzene; useful intermediates for the preparation of angiotensin II antagonists used, for example, in the treatment of hypertension, anxiety, glaucoma and heart failure; provides high yields, is less costly than known procedures |
08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
08/16/2006 | CN1819997A Synthesis of tris n-alkylated 1,4,7,10-tetraazacyclododecanes |
08/16/2006 | CN1269819C Synthesis of temozolomide and analogs |
08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
08/10/2006 | WO2006081807A2 Method for the production of losartan |
08/10/2006 | US20060178413 Diphenylurea derivatives and their use as chloride channel blockers |
08/10/2006 | CA2595962A1 Method for the production of losartan |
08/09/2006 | EP1687258A2 Vitamin d receptor modulators |
08/09/2006 | CN1816533A Pharmaceutical composition comprising valsartan |
08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
08/09/2006 | CN1268615C Substituted benzoylcyclohexenones |
08/09/2006 | CN1268610C Sulfonamide derivatives |
08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
08/03/2006 | WO2006079610A1 Nitrooxy sartan derivatives as angiotensin ii receptor blockers for the treatment of cardiovascular and inflammatory diseases |
08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
08/02/2006 | EP1684748A2 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline |
08/02/2006 | EP1684694A2 Akt protein kinase inhibitors |
08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
08/02/2006 | CN1812967A Cathepsin cysteine protease inhibitors |
07/27/2006 | WO2005051304A3 Akt protein kinase inhibitors |
07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
07/27/2006 | US20060165600 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |